Skip to main content
Clinical Trials/NCT05735223
NCT05735223
Completed
Not Applicable

A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy in Terms of Continence Rates

Larkin Health System1 site in 1 country35 target enrollmentSeptember 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Adenocarcinoma
Sponsor
Larkin Health System
Enrollment
35
Locations
1
Primary Endpoint
Penile Length
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

After robotic prostatectomy, besides erectile function and achievement of oncological control, staying dry is also a very important desire expressed frequently by the patients. This has led to the concept of trifecta achievement after robotic prostatectomies. Hence, continence preserving prostatectomies are the order of the day today. Patient acceptance to surgery is low if the continence cannot be assured preoperatively. Many techniques have been promulgated in the last two decades.

The investigators present a novel technique of maximal urethral length preservation during surgery as an effective method of continence preservation. The investigators hypothesize that maximal preservation of urethra would lead to improved and early continence after robotic prostatectomy. The investigators also hypothesize that urethral preservation spares penile length shortening. The investigators therefore propose to prospectively evaluate penile length shortening.

While penile length change after radical prostatectomy has been studied in the past, the investigators like to assess the penile morphometric assessment following the novel technique of maximal urethral length preservation radical prostatectomy.

Registry
clinicaltrials.gov
Start Date
September 30, 2021
End Date
January 15, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Sponsor
Larkin Health System
Responsible Party
Principal Investigator
Principal Investigator

Balaji Reddy, MD

Principal Investigator

Larkin Health System

Eligibility Criteria

Inclusion Criteria

  • All men undergoing robot assisted laparoscopic radical prostatectomy (RALP).

Exclusion Criteria

  • Exposure to androgen deprivation therapy
  • Prior treatment for prostate cancer
  • Metastatic prostate cancer
  • History of hypospadias or urethral reconstruction
  • History of penile implant, intracorporal injections, intraurethral suppositories
  • Prior pelvic surgery. -

Outcomes

Primary Outcomes

Penile Length

Time Frame: 10 days post operatively

Stretched Flaccid Penile Length

Secondary Outcomes

  • Urinary continence(3 months and 6 months postoperatively)

Study Sites (1)

Loading locations...

Similar Trials